UGT1A3 Inhibitors [MoA] - N0000191275

Name: Table of NDC products with ugt1a3 inhibitors
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000191275
Pharmacologic Name	UGT1A3 Inhibitors
Pharmacologic Uses	thrombopoietin receptor agonist
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with UGT1A3 Inhibitors

The table contains 6 products whose active ingredient are classified under the same pharmacologic class UGT1A3 Inhibitors [MoA].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0078-0684	Promacta	Non-Proprietary Name: Eltrombopag Olamine	Tablet, Film Coated	Oral	Novartis Pharmaceuticals Corporation	ACTIVE
0078-0685	Promacta	Non-Proprietary Name: Eltrombopag Olamine	Tablet, Film Coated	Oral	Novartis Pharmaceuticals Corporation	ACTIVE
0078-0686	Promacta	Non-Proprietary Name: Eltrombopag Olamine	Tablet, Film Coated	Oral	Novartis Pharmaceuticals Corporation	ACTIVE
0078-0687	Promacta	Non-Proprietary Name: Eltrombopag Olamine	Tablet, Film Coated	Oral	Novartis Pharmaceuticals Corporation	ACTIVE
0078-0697	Promacta	Non-Proprietary Name: Eltrombopag Olamine	Powder, For Suspension	Oral	Novartis Pharmaceuticals Corporation	ACTIVE
0078-0972	Promacta	Non-Proprietary Name: Eltrombopag Olamine	Powder, For Suspension	Oral	Novartis Pharmaceuticals Corporation	ACTIVE